(19)
(11) EP 1 156 331 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.08.2009 Bulletin 2009/34

(45) Mention of the grant of the patent:
17.06.2009 Bulletin 2009/25

(21) Application number: 01108773.1

(22) Date of filing: 06.04.2001
(51) International Patent Classification (IPC): 
G01N 33/569(2006.01)
 G01N 33/554(2006.01)

(54)

Immunoassay for H. Pylori in fecal specimens using genus specific monoclonal antibody

Immunoassay für H. pylori in Fäkalienproben mit Hilfe von gattungsspezifischen Antikörpern

Essais immunologique pour H. pylori en épreuves de fèces avec des anticorps genre-spécifiques

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.05.2000 US 574734

(43) Date of publication of application:
21.11.2001 Bulletin 2001/47

(73) Proprietor: MERIDIAN BIOSCIENCE, INC.
Cincinnati, OH 45244 (US)

(72) Inventor:
  • Kozak, Kenneth James
    Cincinnati, Ohio 45255 (US)

(74) Representative: Gowshall, Jonathan Vallance et al
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München
80336 München (DE)


(56) References cited: : 
EP-A- 0 806 667
DE-A- 19 847 628
 WO-A-99/61892
US-A- 5 932 430
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).